Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 374 publications
Publisher Correction: Decade-long persistence of CD19 CAR T cells in B cell lymphomas.
Journal: Nature medicine
Published: August 26, 2026
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.
Journal: The New England journal of medicine
Published: June 24, 2026
A generalizable system for antigenic peptide targeting across HLA-I allotypes.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy.
Journal: The New England journal of medicine
Published: June 03, 2026
HITE: HIV Inspired Lipid Nanoparticle Platform for CAR T Cell Engineering.
Journal: Nano letters
Published: April 21, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptor.
Journal: Blood immunology & cellular therapy
Published: April 17, 2026
A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.
Journal: Journal of hematology & oncology
Published: March 27, 2026
Data-informed optimization of CAR T-cell therapy long-term follow-up.
Journal: Journal for immunotherapy of cancer
Published: March 11, 2026
Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.
Journal: Research square
Published: February 12, 2026
Efficient Production of Chimeric Antigen Receptor (CAR) T Cells with Transgenes Exceeding 10 kb Using Lentiviral Vectors.
Journal: Journal of visualized experiments : JoVE
Published: February 09, 2026
Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer.
Journal: Frontiers in immunology
Published: February 06, 2026
Last Updated: 09/26/2026